title: Multicentric reticulohistiocytosis associated with rheumatoid arthritis.
abstract: Due to the fact that both multicentric reticulohistiocytosis (MRH) and rheumatoid arthritis (RA) are destructive arthritic and skin disorders, it is often difficult to differentiate one from the other. Here, we report the case of a 67-year-old Japanese woman who had been diagnosed as suffering from RA 20 years ago, and who developed MRH. MRH may be misdiagnosed as RA, but evaluation of the time course of specific symptoms can greatly help in the correct diagnosis.
authors.affiliation: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors.forename: Daichi
authors.initials: D
authors.lastname: Hoshina
authors.forename: Tadamichi
authors.initials: T
authors.lastname: Shimizu
authors.forename: Riichiro
authors.initials: R
authors.lastname: Abe
authors.forename: Junko
authors.initials: J
authors.lastname: Murata
authors.forename: Koichi
authors.initials: K
authors.lastname: Tanaka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000188:drug therapy; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015616:Histiocytosis, Non-Langerhans-Cell / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007150:Immunohistochemistry; D008727:Methotrexate / Q000627:therapeutic use*; D010147:Pain Measurement; D011241:Prednisone / Q000627:therapeutic use*; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011241:Prednisone; D008727:Methotrexate